University of New Mexico School of Medicine
Albuquerque, New Mexico
Tudor Oprea, MD PhD is Professor of Medicine and Pharmaceutical Sciences, and Chief, Translational Informatics Division, at the Department of Internal Medicine, University of New Mexico School of Medicine in Albuquerque, New Mexico (USA). He is also Guest Professor at the Institute of Medicine, Gothenburg University in Sweden and at the Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Denmark. To date, Dr. Oprea has co-authored over 225 publications and book chapters, and 9 US patents. Since 2014, Dr. Oprea is PI for the Illuminating the Druggable Genome Knowledge Management Center, a NIH Common Fund initiative. Dr. Oprea’s work led to the drug repositioning of R-ketorolac (REV-440) for ovarian cancer; and the GPER agonist G-1 (LNS8801), which has IND clearance and is evaluated in melanoma. His team processes and integrates data related to genes, drugs, proteins, pathways and clinical records from literature, patents, drug labels and clinical trials, in order to properly map drugs, targets and diseases for drug discovery and repositioning. His most current research is in the development of validated machine learning and artificial intelligence models for target and drug discovery, by combining numerical and free-text information to model human disease biology and therapeutics.
Wednesday, October 28, 2020
11:30 AM – 12:00 PM ET